Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Hair loss in postmenopausal woman caused by ovarian issue.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

PCOS is a long-term condition that needs more research for better understanding and treatment.

PCOS is a major cause of infertility and requires personalized treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.